Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
NCT ID: NCT03009279
Last Updated: 2017-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2017-01-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Analysis for Patients With Metabolic Syndrome
NCT06182618
Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults
NCT01594710
Multi-faceted Evaluations Following Weight Reduction in Subjects With Metabolic Syndrome
NCT01065753
Metabolomics Profiling of Coronary Heart Disease
NCT05138731
Gut Microbiomes in Patients With Metabolic Syndrome
NCT03489317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The MS group
Patients with metabolic syndrome(MS).
No interventions assigned to this group
The non-MS group
Patients without metabolic syndrome(MS).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. signed the informed consent.
3. Have complete clinical data.
Exclusion Criteria
2. People with abnormal thyroid function.
3. Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
4. Pregnant or lactating women.
15 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lin Liao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lin Liao
chief of endocrinology department at Qianfoshan Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lin Liao
Role: STUDY_CHAIR
Qianfoshan Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
qfsnfm-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.